BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 20696863)

  • 1. Separate roles for antigen recognition and lymph node inflammation in CD8+ memory T cell formation.
    Fransen MF; van Stipdonk MJ; Sluijter M; Schoenberger SP; Melief CJ; Offringa R
    J Immunol; 2010 Sep; 185(6):3167-73. PubMed ID: 20696863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD103- and CD103+ bronchial lymph node dendritic cells are specialized in presenting and cross-presenting innocuous antigen to CD4+ and CD8+ T cells.
    del Rio ML; Rodriguez-Barbosa JI; Kremmer E; Förster R
    J Immunol; 2007 Jun; 178(11):6861-6. PubMed ID: 17513734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor masses support naive T cell infiltration, activation, and differentiation into effectors.
    Thompson ED; Enriquez HL; Fu YX; Engelhard VH
    J Exp Med; 2010 Aug; 207(8):1791-804. PubMed ID: 20660615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-12 priming during in vitro antigenic stimulation changes properties of CD8 T cells and increases generation of effector and memory cells.
    Chang J; Cho JH; Lee SW; Choi SY; Ha SJ; Sung YC
    J Immunol; 2004 Mar; 172(5):2818-26. PubMed ID: 14978082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutting edge: antigen presentation to CD8 T cells after influenza A virus infection.
    Ingulli E; Funatake C; Jacovetty EL; Zanetti M
    J Immunol; 2009 Jan; 182(1):29-33. PubMed ID: 19109130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen presentation by an immature myeloid dendritic cell line does not cause CTL deletion in vivo, but generates CD8+ central memory-like T cells that can be rescued for full effector function.
    Dumortier H; van Mierlo GJ; Egan D; van Ewijk W; Toes RE; Offringa R; Melief CJ
    J Immunol; 2005 Jul; 175(2):855-63. PubMed ID: 16002683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung CD103+ dendritic cells efficiently transport influenza virus to the lymph node and load viral antigen onto MHC class I for presentation to CD8 T cells.
    Ho AW; Prabhu N; Betts RJ; Ge MQ; Dai X; Hutchinson PE; Lew FC; Wong KL; Hanson BJ; Macary PA; Kemeny DM
    J Immunol; 2011 Dec; 187(11):6011-21. PubMed ID: 22043017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active dissemination of cellular antigens by DCs facilitates CD8
    Gurevich I; Feferman T; Milo I; Tal O; Golani O; Drexler I; Shakhar G
    Eur J Immunol; 2017 Oct; 47(10):1802-1818. PubMed ID: 28872666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In situ imaging reveals different responses by naïve and memory CD8 T cells to late antigen presentation by lymph node DC after influenza virus infection.
    Khanna KM; Aguila CC; Redman JM; Suarez-Ramirez JE; Lefrançois L; Cauley LS
    Eur J Immunol; 2008 Dec; 38(12):3304-15. PubMed ID: 19009527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PD-1 regulates self-reactive CD8+ T cell responses to antigen in lymph nodes and tissues.
    Keir ME; Freeman GJ; Sharpe AH
    J Immunol; 2007 Oct; 179(8):5064-70. PubMed ID: 17911591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD8+ T cell-dependent elimination of dendritic cells in vivo limits the induction of antitumor immunity.
    Hermans IF; Ritchie DS; Yang J; Roberts JM; Ronchese F
    J Immunol; 2000 Mar; 164(6):3095-101. PubMed ID: 10706699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRTAM confers late-stage activation of CD8+ T cells to regulate retention within lymph node.
    Takeuchi A; Itoh Y; Takumi A; Ishihara C; Arase N; Yokosuka T; Koseki H; Yamasaki S; Takai Y; Miyoshi J; Ogasawara K; Saito T
    J Immunol; 2009 Oct; 183(7):4220-8. PubMed ID: 19752223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activated CD8 T cells redistribute to antigen-free lymph nodes and exhibit effector and memory characteristics.
    Brinkman CC; Sheasley-O'Neill SL; Ferguson AR; Engelhard VH
    J Immunol; 2008 Aug; 181(3):1814-24. PubMed ID: 18641319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics of major histocompatibility class I antigen presentation in acute infection.
    Lay MD; Zhang L; Ribeiro RM; Mueller SN; Belz GT; Davenport MP
    J Immunol; 2009 Jan; 182(2):902-11. PubMed ID: 19124733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and cellular requirements for enhanced antigen cross-presentation to CD8 cytotoxic T lymphocytes.
    Oizumi S; Strbo N; Pahwa S; Deyev V; Podack ER
    J Immunol; 2007 Aug; 179(4):2310-7. PubMed ID: 17675492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient Surface CCR5 Expression by Naive CD8+ T Cells within Inflamed Lymph Nodes Is Dependent on High Endothelial Venule Interaction and Augments Th Cell-Dependent Memory Response.
    Askew D; Su CA; Barkauskas DS; Dorand RD; Myers J; Liou R; Nthale J; Huang AY
    J Immunol; 2016 May; 196(9):3653-64. PubMed ID: 26994221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD8 T cells activated in distinct lymphoid organs differentially express adhesion proteins and coexpress multiple chemokine receptors.
    Ferguson AR; Engelhard VH
    J Immunol; 2010 Apr; 184(8):4079-86. PubMed ID: 20212096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen availability determines CD8⁺ T cell-dendritic cell interaction kinetics and memory fate decisions.
    Henrickson SE; Perro M; Loughhead SM; Senman B; Stutte S; Quigley M; Alexe G; Iannacone M; Flynn MP; Omid S; Jesneck JL; Imam S; Mempel TR; Mazo IB; Haining WN; von Andrian UH
    Immunity; 2013 Sep; 39(3):496-507. PubMed ID: 24054328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against influenza A virus by memory CD8 T cells requires reactivation by bone marrow-derived dendritic cells.
    Castiglioni P; Hall de S; Jacovetty EL; Ingulli E; Zanetti M
    J Immunol; 2008 Apr; 180(7):4956-64. PubMed ID: 18354221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IFN-gamma receptor signaling regulates memory CD8+ T cell differentiation.
    Sercan O; Stoycheva D; Hämmerling GJ; Arnold B; Schüler T
    J Immunol; 2010 Mar; 184(6):2855-62. PubMed ID: 20164422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.